World's first medical networking and resource portal

News & Highlights
Please make use of the search function to browse preferred content
Medical News & Updates
Jul 12
Consuming raw fruit, veggies boosts mental health: Study
A new study has found that eating raw fruit and vegetables such as kiwis, bananas, apples and dark leafy greens may lower symptoms of depression and improve mental health, more than cooked, canned and processed food.

Consuming raw fruits and vegetables leads to lower levels of mental illness symptomology, such as depression, as per the findings. It also improved levels of psychological well-being including a positive mood and life satisfaction.

Lead author Tamlin Conner, senior lecturer at the University of Otago in Dunedin, New Zealand said, "Our research has highlighted that the consumption of fruit and vegetables in their 'unmodified' state is more strongly associated with better mental health compared to cooked/canned/processed fruit and vegetables."

Conner said, when the fruits and vegetables are cooked, canned and processed, they lose their mental health benefits as the process potentially diminishes the nutrient levels.

"Cooking and processing likely limits the delivery of nutrients that are essential for optimal emotional functioning," Conner added.

For the study more than 400 young adults from New Zealand and the US aged 18 to 25 years were surveyed.

Conner says public health campaigns have historically focused on aspects of quantity for the consumption of fruit and vegetables (such as 5+ a day).

However, the new study found that for mental health in particular, it may also be important to consider the way in which produce was prepared and consumed.

"This research is increasingly vital as lifestyle approaches such as dietary change may provide an accessible, safe and adjuvant approach to improving mental health," Conner said.

The study was published in the journal Frontiers in Psychology.

Jul 12
Using e-cigarettes can harm your liver, says study
For most people, the topic of e-cigarette safety is of constant debate. Is it safer than normal cigarettes or is it more harmful? Does it induce the habit of smoking tobacco or increase the chances of fatality?

Many studies on these vaping pens have shown contradictory results while some say, it reduces the impulse to smoke cigarettes as well as the risk of death, others have said the complete opposite.

Two studies carried out last year, for instance, had contradictory evidence to show. While one said that vaping could reduce mortality rate, the other said that the practice may double the risk of smoking.

Now, as the government continues to caution people against tobacco and e-cigarettes, a new study has suggested that the use of e-cigarettes may lead to an accumulation of fat in the liver.

The study exposed mice to the devices to come to the conclusion.

"The popularity of electronic cigarettes has been rapidly increasing in part because of advertisements that they are safer than conventional cigarettes. But because extra fat in the liver is likely to be detrimental to health, we conclude that e-cigarettes are not as safe as they have been promoted to consumers," said lead author Theodore C. Friedman of Charles R Drew University of Medicine and Science in Los Angeles, Calif. "This has important public health and regulatory implications."

E-cigarettes contain nicotine, which Dr Friedman and other researchers have reported is associated with non-alcohol fatty liver diseases. However, the long-term effects of e-cigarettes on liver disease, diabetes, heart disease or stroke are unknown.

In the 12-week study, Friedman and colleagues studied mice missing the gene for apolipoprotein E, which makes them more prone to developing heart disease and fat in the liver. All of the mice were fed a diet relatively high in fat and cholesterol.

One group of mice was put in a chamber that exposed them to e-cigarette aerosol so that their blood nicotine levels were similar to that of smokers and e-cigarette users. The second group of mice were exposed to saline aerosol.

The researchers collected liver samples and looked at genes in the liver affected by e-cigarettes using a technique called RNA sequence analysis. They found changes in 433 genes that were associated with fatty liver development and progression in the mice exposed to e-cigarettes.

The researchers also found that genes related to circadian rhythms (the body clock) were changed in mice exposed to e-cigarettes. Circadian rhythm dysfunction is known to accelerate the development of liver disease including fatty liver diseases.

"Our experimental results will provide support to policymakers and federal and state regulatory bodies to take preventive measures to stop the increasing use of e-cigarettes among both children and adults," Friedman said.

The research was presented at ENDO 2018, the Endocrine Society's 100th annual meeting in Chicago, Ill.

Jul 12
Self-esteem key to treat mental health patients: Study
Improving how mental health patients perceive themselves can be critical in treating them, a first of its kind study has claimed.

The findings of the study suggest that youths with psychiatric disorders, currently receiving inpatient services, reported lower self-concept, particularly global self-worth, compared to those receiving outpatient services.

"This was the first study that examined youth with a psychiatric disorder by comparing what type of service they were receiving and whether that was associated with self-concept," said Mark Ferro, Assistant Professor at the University of Waterloo.

"We know that global self-worth is lower in the inpatient group and we know from other research that lower self-concept is a precursor to other more serious mental health problems," Ferro said.

For the study, published in the Journal of the Canadian Academy of Child and Adolescent Psychiatry, researchers examined a group of youth aged between 8-17 years who were receiving inpatient and outpatient psychiatric services.

The participants' self-concept was measured using the Self-Perception Profile for Children and Adolescents.

According to the researchers, self-concept might be an important aspect to consider when implementing treatment programmes to improve the mental health of youth who are hospitalized.

"Because youths who are in the inpatient service have a lower self-concept, therapies within their overall treatment program aiming to improve self-worth might be worthwhile," the researcher noted.

Jul 12
Monthly dose of new antibody may halve migraine attacks
In a breakthrough, scientists have found an antibody, a monthly dose of which could halve the number of debilitating attacks of migraine on patients who have exhausted all other treatments.

The findings showed that people treated with erenumab were nearly three times more likely to have reduced their migraine days by 50 percent or more than those treated with placebo.

Those treated with erenumab also had a greater average reduction in the number of days they had headaches and the number of days they needed to take drugs to stop the migraines.

"Our study found that erenumab reduced the average number of monthly migraine headaches by more than 50 percent for nearly a third of study participants. That reduction in migraine headache frequency can greatly improve a person's quality of life," said Uwe Reuter from The Charite - University Medicine Berlin in Germany.

Erenumab is a monoclonal antibody that blocks pain signals by targeting a receptor for calcitonin gene-related peptide (CGRP).

This peptide transmits migraine pain signals. Erenumab occupies the nerves to which CGRP would usually bind.

"Our results show that people who thought their migraines were difficult to prevent may actually have hope of finding pain relief," Reuter added.

The preliminary results will be presented at the forthcoming American Academy of Neurology's 70th Annual Meeting in Los Angeles.

For the study, 246 people who had episodic migraine were given injections of either 140 milligrams of erenumab or a placebo once a month for three months.

Of the participants, 39 per cent had been treated unsuccessfully with two other medications, 38 per cent with three medications and 23 per cent with four medications.

A total of 30 per cent of the people treated with erenumab had half the number of headaches compared to 14 per cent on placebo.

For those on erenumab, there was an average 1.6 times greater reduction in migraine days and a 1.7 times greater reduction in acute medication days compared to those on placebo.

In addition, the safety and tolerability of erenumab was similar to placebo. However, more research is now needed to understand who is most likely to benefit from this new treatment, Reuter said.

Jul 12
Sleep problems may indicate multiple
Scientists have found that multiple sclerosis (MS) may be identified at least five years earlier as the patients were more likely to undergo treatments for nervous system disorders like pain or sleep problems, according to a study.

MS results from the body's immune system attacking myelin -- fatty material that enables rapid transmission of electrical signals -- which disrupts the communication between the brain and other parts of the body, leading to vision problems, muscle weakness, difficulty with balance and coordination, and cognitive impairments.

"The existence of such `warning signs` are well-accepted for Alzheimer`s disease and Parkinson`s disease, but there has been little investigation into a similar pattern for MS," said lead researcher Helen Tremlett from the Division of Neurology at the University of British Columbia in Canada.

"We now need to delve deeper into this phenomenon, perhaps using data-mining techniques. We want to see if there are discernible patterns related to sex, age or the `type` of MS they eventually develop," Tremlett added.

For the study, published in the Multiple Sclerosis Journal, the team examined health records of 14,000 people with multiple sclerosis and compared them to the health records of 67,000 people without the disease.

Fibromyalgia -- a condition involving widespread musculoskeletal pain -- was found more than three times in people who were later diagnosed with MS as compared to those who did not.

Irritable bowel syndrome was almost twice as common in people who developed the disorder. Migraine headaches and any mood or anxiety disorder, which includes depression, anxiety and bipolar disorder were also found in higher rates among the group.

Further, higher rates of these illnesses also correspond with higher use of medications for musculoskeletal disorders, nervous system disorders, and disorders of the genito-urinary tract, along with antidepressants and antibiotics.

The findings may enable physicians to diagnose the disease earlier and start the treatment, thus possibly slowing the damage it causes to the brain and spinal cord.

Jul 12
Smelling coffee may boost your analytical skills for GMAT
If you love the fragrance of coffee, there are high chances of better performance in analytical tasks, a new study has found.

According to the researchers, smelling a coffee-like scent -- which has no caffeine in it -- has an effect similar to that of drinking coffee, suggesting a placebo effect of coffee scent.

The findings also suggested that the scent of coffee alone may help people perform better on the analytical portion of the Graduate Management Aptitude Test (GMAT) -- a computer adaptive test required by many business schools.

"It`s not just that the coffee-like scent helped people perform better on analytical tasks, which was already interesting," said co-author Adriana Madzharov from the Stevens Institute of Technology in the US.

"But they also thought they would do better, and we demonstrated that this expectation was at least partly responsible for their improved performance," Madzharov added.

For the study, published in the Journal of Environmental Psychology, the research team administered a 10-question GMAT algebra test in a computer lab to about 100 undergraduate business students.

The participants were divided into two groups. One group took the test in the presence of an ambient coffee-like scent, while a control group took the same test -- but in an unscented room.

The researchers found that the group in the coffee-smelling room scored significantly higher on the test.

The team also designed a follow-up survey -- conducted among more than 200 new participants -- quizzing them on beliefs about various scents and their perceived effects on human performance.

The participants believed they would feel more alert and energetic in the presence of a coffee scent, versus a flower scent or no scent; and that exposure to coffee scent would increase their performance on mental tasks.

The results suggest that expectations about performance can be explained by beliefs that coffee scent alone makes people more alert and energetic.

Previous studies have also suggested that coffee may lessen the risk of heart disease, diabetes and dementia.

Browse Archive